PUMA-Mediated Apoptosis Drives Chemical Hepatocarcinogenesis in Mice

被引:73
作者
Qiu, Wei
Wang, Xinwei
Leibowitz, Brian
Yang, Wancai [3 ]
Zhang, Lin [2 ]
Yu, Jian [1 ]
机构
[1] Univ Pittsburgh, Hillman Canc Ctr Res Pavil, Sch Med, Univ Pittsburgh Canc Inst,Dept Pathol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA
[3] Univ Illinois, Dept Pathol, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; BH3-ONLY PROTEINS; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; LIVER INFLAMMATION; CANCER CELLS; DNA-DAMAGE; STEM-CELLS; TUMORIGENESIS; BCL-2;
D O I
10.1002/hep.24516
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocyte death and proliferation contribute to hepatocellular carcinoma development after carcinogen exposure or chronic liver inflammation. However, the role and the molecular targets of hepatocyte death in relation to compensatory proliferation have not been fully characterized. In this study, we investigated the role of p53 up-regulated modulator of apoptosis (PUMA), a BH3-only protein important for both p53-dependent and -independent apoptosis, in a diethylnitrosamine (DEN)-induced liver carcinogenesis model. PUMA deficiency significantly decreased the multiplicity and size of liver tumors. DEN treatment induced p53-independent PUMA expression, PUMA-dependent hepatocyte death, and compensatory proliferation. Furthermore, inhibition or deletion of c-jun N-terminal kinase 1 (JNK1) abrogated PUMA induction, hepatocyte death, and compensatory proliferation. Conclusion: These results provide direct evidence that JNK1/PUMA-dependent apoptosis promotes chemical hepatocarcinogenesis through compensatory proliferation, and suggest apoptotic inducers as potential therapeutic targets in liver injury and cancer. (HEPATOLOGY 2011;54:1249-1258)
引用
收藏
页码:1249 / 1258
页数:10
相关论文
共 57 条
[11]   Hepatocellular carcinoma pathogenesis: from genes to environment [J].
Farazi, Paraskevi A. ;
DePinho, Ronald A. .
NATURE REVIEWS CANCER, 2006, 6 (09) :674-687
[12]  
FEINBERG A, 1980, CANCER RES, V40, P4446
[13]   Heterozygous p53-deficient (±) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice [J].
Finnberg, N ;
Stenius, U ;
Högberg, J .
CANCER LETTERS, 2004, 207 (02) :149-155
[14]   Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis [J].
Garrison, Sean P. ;
Jeffers, John R. ;
Yang, Chunying ;
Nilsson, Jonas A. ;
Hall, Mark A. ;
Rehg, Jerold E. ;
Yue, Wen ;
Yu, Jian ;
Zhang, Lin ;
Onciu, Mihaela ;
Sample, Jeffery T. ;
Cleveland, John L. ;
Zambetti, Gerard P. .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (17) :5391-5402
[15]   IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer [J].
Greten, FR ;
Eckmann, L ;
Greten, TF ;
Park, JM ;
Li, ZW ;
Egan, LJ ;
Kagnoff, MF ;
Karin, M .
CELL, 2004, 118 (03) :285-296
[16]   NF-κB and STAT3 - key players in liver inflammation and cancer [J].
He, Guobin ;
Karin, Michael .
CELL RESEARCH, 2011, 21 (01) :159-168
[17]   Suppression of tumorigenesis by the p53 target PUMA [J].
Hemann, MT ;
Zilfou, JT ;
Zhao, Z ;
Burgess, DJ ;
Hannon, GJ ;
Lowe, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (25) :9333-9338
[18]   BH3-Only proteins - Essential initiators of apoptotic cell death [J].
Huang, DCS ;
Strasser, A .
CELL, 2000, 103 (06) :839-842
[19]   TP53 mutations and hepatocellular carcinoma:: insights into the etiology and pathogenesis of liver cancer [J].
Hussain, S. P. ;
Schwank, J. ;
Staib, F. ;
Wang, X. W. ;
Harris, C. C. .
ONCOGENE, 2007, 26 (15) :2166-2176
[20]   Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells [J].
Hwang, PM ;
Bunz, F ;
Yu, J ;
Rago, C ;
Chan, TA ;
Murphy, MP ;
Kelso, GF ;
Smith, RAJ ;
Kinzler, KW ;
Vogelstein, B .
NATURE MEDICINE, 2001, 7 (10) :1111-1117